{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-25-052719","form_type":"8-K","ticker":"DFTX","cik":"0001813814","company_name":"Definium Therapeutics, Inc.","filed_at":"2025-05-27T23:59:59+00:00","discovered_at":"2026-05-14T18:02:49.835099+00:00","generated_at":"2026-05-20T11:16:35.612230+00:00","sec_items":["5.02","7.01","9.01"],"event_type":"leadership","sentiment":"positive","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"MindMed appoints Brandi Roberts as CFO effective June 2, 2025; inducement awards granted","bullets":["Roberts previously CFO of Longboard Pharmaceuticals, led IPO and $2.6B Lundbeck acquisition.","Base salary $495,000; eligible for annual cash bonus up to 40% of base salary.","Inducement awards: option for 500,000 shares (4-year vest) and 125,000 PSUs (3-year vest, 0-200% payout).","Roberts replaces Carrie Liao as principal financial and accounting officer effective June 2."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-25-052719","json":"https://secwatch.observer/filing/0001104659-25-052719.json","markdown":"https://secwatch.observer/filing/0001104659-25-052719.md","text":"https://secwatch.observer/filing/0001104659-25-052719.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1813814/000110465925052719/0001104659-25-052719-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1813814/000110465925052719/tm2516110d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-20T11:16:35.612230+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"2a118ce96b","claim":"Brandi L. Roberts was appointed as Chief Financial Officer at Definium Therapeutics, Inc..","evidence_excerpt":"had appointed Brandi L. Roberts as Chief Financial Officer, effective as of June 2, 2025 (the “Effective Date”).","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1813814/000110465925052719/0001104659-25-052719-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Chief Financial Officer"}],"fact_type":"executive_change"},{"claim_id":"4de36a3ea3","claim":"Carrie Liao changed role as principal financial officer and principal accounting officer at Definium Therapeutics, Inc..","evidence_excerpt":"Carrie Liao, the Company’s Chief Accounting Officer, will no longer serve as the Company’s principal financial officer and principal accounting officer.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1813814/000110465925052719/0001104659-25-052719-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"will no longer serve as"},{"label":"Role","value":"principal financial officer and principal accounting officer"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}